» Articles » PMID: 30459813

Pilot Safety Evaluation of a Novel Strain of

Overview
Journal Front Genet
Date 2018 Nov 22
PMID 30459813
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

ELH-B2 is considered as a potential next-generation probiotic due to its preventive effects on lipopolysaccharides-associated inflammation and intestinal microbiota disorders in mice. To study safety issues associated with ELH-B2, we conducted comprehensive and systematic experiments, including genetic assessments of potential virulence and antimicrobial resistance genes, and an acute toxicity study of both immunocompetent and immunosuppressed mice via cyclophosphamide treatment. The results indicated that this novel strain is non-toxigenic, fragilysin is not expressed, and most of potential virulence genes are correlated with cellular structures such as capsular polysaccharide and polysaccharide utilizations. The antibiotic resistance features are unlikely be transferred to other intestinal microorganisms as no plasmids nor related genomic islands were identified. Side effects were not observed in mice. ELH-B2 also alleviated the damages caused by cyclophosphamide injection.

Citing Articles

Unraveling Whole-Genome Sequence and Functional Characterization of PH3.

Zhang X, Liang J, Zhang D, Wang L, Ye S Foods. 2024; 13(22).

PMID: 39593971 PMC: 11593290. DOI: 10.3390/foods13223555.


Non-lactic acid bacteria probiotics isolated from intestine or various circumstances.

Lee N, Jang H, Paik H Food Sci Biotechnol. 2024; 33(9):1997-2007.

PMID: 39130655 PMC: 11315843. DOI: 10.1007/s10068-024-01608-x.


Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.

Aliwa B, Horvath A, Traub J, Feldbacher N, Habisch H, Fauler G J Cachexia Sarcopenia Muscle. 2023; 14(6):2676-2691.

PMID: 37767786 PMC: 10751428. DOI: 10.1002/jcsm.13342.


Case Report: The effect of intravenous and oral antibiotics on the gut microbiome and breath volatile organic compounds over one year.

Shahi F, Forrester S, Redeker K, Chong J, Barlow G Wellcome Open Res. 2023; 7:50.

PMID: 36874581 PMC: 9975432. DOI: 10.12688/wellcomeopenres.17450.3.


Changes in fecal microbiota composition and the cytokine expression profile in school-aged children with depression: A case-control study.

Ling Z, Cheng Y, Chen F, Yan X, Liu X, Shao L Front Immunol. 2022; 13:964910.

PMID: 36059521 PMC: 9437487. DOI: 10.3389/fimmu.2022.964910.


References
1.
Hamady Z, Scott N, Farrar M, Lodge J, Holland K, Whitehead T . Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut. 2009; 59(4):461-9. DOI: 10.1136/gut.2008.176131. View

2.
Hirsh M, Carmel J, Kaplan V, Livne E, Krausz M . Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis. Int J Exp Pathol. 2004; 85(3):147-57. PMC: 2517469. DOI: 10.1111/j.0959-9673.2004.00385.x. View

3.
Kennedy A, Bubeck Wardenburg J, Gardner D, Long D, Whitney A, Braughton K . Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis. 2010; 202(7):1050-8. PMC: 2945289. DOI: 10.1086/656043. View

4.
Gong Y, Wu J, Li S . Immuno-enhancement effects of Lycium ruthenicum Murr. polysaccharide on cyclophosphamide-induced immunosuppression in mice. Int J Clin Exp Med. 2016; 8(11):20631-7. PMC: 4723828. View

5.
Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S . Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. Appl Environ Microbiol. 2011; 78(2):528-35. PMC: 3255732. DOI: 10.1128/AEM.06641-11. View